Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Tofacitinib in Oral Lichen Planus
NCT07131813Phase 4Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of INN-04-01 in oral lichen planus (OLP), sponsored by AIIMS New Delhi. Started Oct 2025; status: recruiting.
02
Drugs
INN-04-01
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT07131813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131813.